[
  {
    "ts": null,
    "headline": "Vertex and Orna sign partnership to improve efficiencies of gene therapies",
    "summary": "Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.",
    "url": "https://finnhub.io/api/news?id=7636f2207ae6674c6ad14bdd731d1d36d214ecd8e8b7d60050d2e084399351ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736338863,
      "headline": "Vertex and Orna sign partnership to improve efficiencies of gene therapies",
      "id": 132316166,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2025/01/GettyImages-1916729901-e1736334692695.jpg",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.",
      "url": "https://finnhub.io/api/news?id=7636f2207ae6674c6ad14bdd731d1d36d214ecd8e8b7d60050d2e084399351ba"
    }
  },
  {
    "ts": null,
    "headline": "Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia",
    "summary": "WATERTOWN - Orna Therapeutics announced a three-year strategic research collaboration with Vertex Pharmaceuticals Incorporated to utilize Orna's novel and proprietary LNP delivery solutions to...",
    "url": "https://finnhub.io/api/news?id=c047f12ce5ad5d71f0894e6285beca7cf932a45cb7d0d0894ddd06d1b1f74f97",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736330065,
      "headline": "Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia",
      "id": 132315965,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "WATERTOWN - Orna Therapeutics announced a three-year strategic research collaboration with Vertex Pharmaceuticals Incorporated to utilize Orna's novel and proprietary LNP delivery solutions to...",
      "url": "https://finnhub.io/api/news?id=c047f12ce5ad5d71f0894e6285beca7cf932a45cb7d0d0894ddd06d1b1f74f97"
    }
  },
  {
    "ts": null,
    "headline": "2024 Performance Review And Future Strategy",
    "summary": "My 2024 picks outperformed the S&P 500, mainly due to Tesla, but small biotech firms lagged significantly. Learn more about my 2024 performance here.",
    "url": "https://finnhub.io/api/news?id=3922811a6b45756cc6f38314d6b95f2b71818045c9380e9535a68114ed74797a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736307720,
      "headline": "2024 Performance Review And Future Strategy",
      "id": 132312972,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "My 2024 picks outperformed the S&P 500, mainly due to Tesla, but small biotech firms lagged significantly. Learn more about my 2024 performance here.",
      "url": "https://finnhub.io/api/news?id=3922811a6b45756cc6f38314d6b95f2b71818045c9380e9535a68114ed74797a"
    }
  }
]